Briacell Therapeutics Corp.
BCTX and BCTXL • NASDAQ
Briacell Therapeutics Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William V. Williams, with a market cap of $27.2M.
Market Cap$27.2M
Employees12.0
CEOWilliam V. Williams
CountryCanada
Healthcare
Biotechnology
Next EarningsJun 15, 2026 · in 2 monthsQ3 2026
Financials
Briacell Therapeutics Corp. FAQ
Common questions about Briacell Therapeutics Corp.
Briacell Therapeutics Corp. is scheduled to report earnings for Q3 2026 on June 15, 2026.
Briacell Therapeutics Corp. has approximately 12 employees.